Remove 2019 Remove Epilepsy Remove Events Remove Medicine
article thumbnail

And Here We Go Again! NASDAQ Article: Forget Cannabis: Psychedelic Medicine Is the Better Investing Opportunity

Cannabis Law Report

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. In lockstep with the FDA’s more open-minded approach toward psychedelic medicine, Denver, Oakland, and Santa Cruz all decided to decriminalize magic mushrooms. Hundreds of other U.S.

article thumbnail

Dentons: Recent medicinal cannabis developments in Australia

Cannabis Law Report

There have recently been a series of developments advancing the Australian medicinal cannabis industry. The Narcotic Drugs Act 1967 (Cth) ( ND Act ) establishes a licence and permit scheme to regulate the cultivation, production and manufacture of medicinal cannabis.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales

Cannabis Law Report

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m.

article thumbnail

NORML 2019 Legislative Report

Cannabis Law Report

This report contains a detailed summary of 2019’s federal and state legislative victories.” 2019 has been an unprecedented year for the passage of state-level marijuana law reforms. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019.

article thumbnail

CBD Market Report

Project CBD

The following excerpt analyzes CBD marketing trends reported by the American Botanical Council, a membership organization that educates consumers, health care professionals, journalists, and others about the safe and effective use of medicinal plants. Sales appear to have peaked in 2019, when natural channel consumers spent more than $90.7

CBD 144
article thumbnail

BBC Report: EU Approves , “Epidyolex” GW Pharmaceuticals

Cannabis Law Report

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. September 23, 2019. What do experts say?

article thumbnail

Cannabis & Coronavirus – A Pharmacist’s Perspective

CannaTech

In practical terms, we studied how pharmaceuticals interact, how to accurately measure and dispense medications, advise patients on effective protocols and adverse events, what to do and not to do when using specific medications. In 2019, I completed the Israel Ministry of Health’s cannabis curriculum for pharmacists.